Molina Healthcare (MOH)
(Delayed Data from NYSE)
$352.30 USD
-15.11 (-4.11%)
Updated Apr 25, 2024 04:02 PM ET
After-Market: $348.99 -3.31 (-0.94%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum C VGM
Price, Consensus and EPS Surprise
MOH 352.30 -15.11(-4.11%)
Will MOH be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MOH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MOH
Community Health (CYH) Q1 Earnings Top on Better Occupancy Rates
Molina Healthcare (MOH) Q1 Earnings Beat on Growing Membership
MOH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Universal Health (UHS) Q1 Earnings Beat on Rising Patient Days
Molina (MOH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Watch These 5 Medical Stocks for Q1 Earnings: Beat or Miss?
Other News for MOH
Molina Healthcare Inc (MOH) Q1 2024 Earnings Call Transcript Highlights: Strong Performance and ...
Decoding Molina Healthcare Inc (MOH): A Strategic SWOT Insight
Truist Financial Keeps Their Buy Rating on Molina Healthcare (MOH)
Molina Healthcare: Revenue Upside Clashes with MLR Concerns, Justifying Underperform Rating
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Biogen (BIIB) and Molina Healthcare (MOH)